Screener
Mirion Technologies MIR Nuclear & Safety — Total revenues
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Mirion Technologies in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Mirion Technologies’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050604
| Line item | Nuclear & Safety | Medical | Total |
|---|---|---|---|
| Revenues | $186.2 | $80.6 | $266.8 |
| Less: | |||
| Adjusted cost of revenues (1) | 93.3 | 26.5 | 119.8 |
| Other segment items (2) | 66.9 | 39.3 | 106.2 |
| Segment income from operations | $26.0 | $14.8 | $40.8 |
| Other loss (3) | (22.9) | ||
| Income from operations | 17.9 | ||
| Less other expense (income): |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Mirion Technologies's nuclear & safety — total revenues?
- Mirion Technologies (MIR) reported nuclear & safety — total revenues of $186.2M in Q2 2026.
- How has Mirion Technologies's nuclear & safety — total revenues changed year-over-year?
- Mirion Technologies's nuclear & safety — total revenues increased by 31.4% year-over-year, from $141.7M to $186.2M.
- What is the long-term trend for Mirion Technologies's nuclear & safety — total revenues?
- Over 3 years (2022 to 2025), Mirion Technologies's nuclear & safety — total revenues has grown at a 11.3% compound annual growth rate (CAGR), from $446.1M to $614.6M.
- What does nuclear & safety — total revenues mean?
- Represents the total gross revenue generated by the Nuclear and Safety business segment from the sale of products and services. This metric reflects the market demand and commercial performance of the segment's specialized radiation safety and measurement solutions.
Ask your AI about Mirion Technologies's nuclear & safety — total revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude